BDBM476174 (−)-N1-norphenylcarbamoyleseroline::US10864192, Compound N-1 Nor P

SMILES: CN1[C@H]2NCC[C@@]2(C)c2cc(OC(=O)Nc3ccccc3)ccc12

InChI Key: InChIKey=ITTCFQIHBIBVEN-MJGOQNOKSA-N

Data: 1 EC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 476174   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Acetylcholinesterase (Homo sapiens (Human))	BDBM476174 ((−)-N1-norphenylcarbamoyleseroline | US10864...) Show SMILES CN1[C@H]2NCC[C@@]2(C)c2cc(OC(=O)Nc3ccccc3)ccc12 |r| Show InChI InChI=1S/C19H21N3O2/c1-19-10-11-20-17(19)22(2)16-9-8-14(12-15(16)19)24-18(23)21-13-6-4-3-5-7-13/h3-9,12,17,20H,10-11H2,1-2H3,(H,21,23)/t17-,19+/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	62	n/a	n/a	n/a	n/a
Aristea Translational Medicine Corporation US Patent					Assay Description To address these issues, the present disclosure relates to the development and utilization of a (−)-phenserine extended release formulation. To...				US Patent US10864192 (2020)
					More data for this Ligand-Target Pair